MACOP-B regimen: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{SI}} {{CMG}}; {{AE}} {{AV}} {{SK}}MACOP-B Regimen; Methotrexate-Adriamycin-Cytoxan-Oncovin-Prednisone-Bleomycin Regimen ==Overview== {{PAGENAME}} refers to a reg...")
 
No edit summary
 
(One intermediate revision by the same user not shown)
Line 9: Line 9:


==Regimen==
==Regimen==
{{chemo|M|Methotrexate}}
{{chemo|M|Methotrexate}}


{{chemo|A|Doxorubicin (Adriamycin)}}
{{chemo|A|Doxorubicin (Adriamycin)}}
{{chemo|C|Cyclophosphamide}}
{{chemo|C|Cyclophosphamide}}
{{chemo|O|Vincristine (Oncovin)}}
{{chemo|O|Vincristine (Oncovin)}}


Line 20: Line 21:
{{chemo|B|Bleomycin}}
{{chemo|B|Bleomycin}}


==Indications== *[[Non-Hodgkin's lymphoma]]<ref name="pmid18472357">{{cite journal| author=De Sanctis V, Finolezzi E, Osti MF, Grapulin L, Alfò M, Pescarmona E et al.| title=MACOP-B and involved-field radiotherapy is an effective and safe therapy for primary mediastinal large B cell lymphoma. | journal=Int J Radiat Oncol Biol Phys | year= 2008 | volume= 72 | issue= 4 | pages= 1154-60 | pmid=18472357 | doi=10.1016/j.ijrobp.2008.02.036 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18472357 }} </ref><ref>{{Cite web | title = NCI Thesaurus | accessdate =  | url = http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C63457&ns=NCI_Thesaurus }}</ref>
==Indications==  
==References== {{Reflist|2}}  [[Category:Chemotherapy regimens]]
*[[Non-Hodgkin's lymphoma]]<ref name="pmid18472357">{{cite journal| author=De Sanctis V, Finolezzi E, Osti MF, Grapulin L, Alfò M, Pescarmona E et al.| title=MACOP-B and involved-field radiotherapy is an effective and safe therapy for primary mediastinal large B cell lymphoma. | journal=Int J Radiat Oncol Biol Phys | year= 2008 | volume= 72 | issue= 4 | pages= 1154-60 | pmid=18472357 | doi=10.1016/j.ijrobp.2008.02.036 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18472357 }} </ref><ref>{{Cite web | title = NCI Thesaurus | accessdate =  | url = http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C63457&ns=NCI_Thesaurus }}</ref>
 
==References==  
{{Reflist|2}}  
   
[[Category:Chemotherapy regimens]]

Latest revision as of 15:50, 27 March 2015

WikiDoc Resources for MACOP-B regimen

Articles

Most recent articles on MACOP-B regimen

Most cited articles on MACOP-B regimen

Review articles on MACOP-B regimen

Articles on MACOP-B regimen in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on MACOP-B regimen

Images of MACOP-B regimen

Photos of MACOP-B regimen

Podcasts & MP3s on MACOP-B regimen

Videos on MACOP-B regimen

Evidence Based Medicine

Cochrane Collaboration on MACOP-B regimen

Bandolier on MACOP-B regimen

TRIP on MACOP-B regimen

Clinical Trials

Ongoing Trials on MACOP-B regimen at Clinical Trials.gov

Trial results on MACOP-B regimen

Clinical Trials on MACOP-B regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on MACOP-B regimen

NICE Guidance on MACOP-B regimen

NHS PRODIGY Guidance

FDA on MACOP-B regimen

CDC on MACOP-B regimen

Books

Books on MACOP-B regimen

News

MACOP-B regimen in the news

Be alerted to news on MACOP-B regimen

News trends on MACOP-B regimen

Commentary

Blogs on MACOP-B regimen

Definitions

Definitions of MACOP-B regimen

Patient Resources / Community

Patient resources on MACOP-B regimen

Discussion groups on MACOP-B regimen

Patient Handouts on MACOP-B regimen

Directions to Hospitals Treating MACOP-B regimen

Risk calculators and risk factors for MACOP-B regimen

Healthcare Provider Resources

Symptoms of MACOP-B regimen

Causes & Risk Factors for MACOP-B regimen

Diagnostic studies for MACOP-B regimen

Treatment of MACOP-B regimen

Continuing Medical Education (CME)

CME Programs on MACOP-B regimen

International

MACOP-B regimen en Espanol

MACOP-B regimen en Francais

Business

MACOP-B regimen in the Marketplace

Patents on MACOP-B regimen

Experimental / Informatics

List of terms related to MACOP-B regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords:MACOP-B Regimen; Methotrexate-Adriamycin-Cytoxan-Oncovin-Prednisone-Bleomycin Regimen

Overview

MACOP-B regimen refers to a regimen consisting of methotrexate, doxorubicin (adriamycin), cyclophosphamide, vincristine (Oncovin) and prednisone, bleomycin used to treat aggressive forms of non-Hodgkin's lymphoma.[1][2]

Regimen

MMethotrexate

ADoxorubicin (Adriamycin)

CCyclophosphamide

OVincristine (Oncovin)

PPrednisone

BBleomycin

Indications

References

  1. 1.0 1.1 De Sanctis V, Finolezzi E, Osti MF, Grapulin L, Alfò M, Pescarmona E; et al. (2008). "MACOP-B and involved-field radiotherapy is an effective and safe therapy for primary mediastinal large B cell lymphoma". Int J Radiat Oncol Biol Phys. 72 (4): 1154–60. doi:10.1016/j.ijrobp.2008.02.036. PMID 18472357.
  2. "NCI Thesaurus".
  3. "NCI Thesaurus".